Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care in Texas

August 15, 2023 updated by: Elizabeth Arnold

Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care in Texas: CRT

The overall aim of this study is to reduce suicide among sexual and gender diverse youth ages 18-24 years old. This study will compare the effectiveness of two brief suicide prevention interventions that have been adapted for use with this population to use in primary care via telehealth and will recruit youth from primary care clinics in Texas metropolitan areas. The primary study outcome is suicidal ideation. Each clinic will be randomly assigned to deliver one of the two study interventions.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

1485

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Texas
      • Austin, Texas, United States, 78712
        • Recruiting
        • Dell Medical School at The University of Texas at Austin
        • Contact:
          • Phillip Schnarrs, PhD
      • Dallas, Texas, United States, 75390
        • Recruiting
        • University of Texas Southwestern Medical Center
        • Contact:
          • Emily Levy-Kamugisha, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • be aged 18-24 at the time of enrollment
  • not have received mental health services in the past 90 days, excluding medication and case management
  • English-speaking
  • screen positive for suicide risk

Exclusion Criteria:

  • are actively suicidal
  • have a developmental disability that would preclude them from participating in the study intervention
  • who are impaired due to psychosis, mania, or substance use that would prevent them from providing consent.
  • Participants will also be excluded at YST-III sites if they are unable to identify a minimum of one support person to participate in the intervention with them

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Suicidal Teens Accessing Treatment - Primary Care (STAT-PC)
This group will participate in a brief, suicide prevention intervention based on motivational interviewing that focuses on mental health care seeking behavior, problem-solving, and referrals plus brief case management that has been adapted.
STAT-PC is an adapted version of Suicidal Teens Accessing Treatment after an ED Visit (STAT-ED). It is a brief intervention based on motivational interviewing (MI) that focuses on mental health care seeking behavior, problem-solving, and referrals plus brief case management. The intervention will consist of an initial session with the youth focusing on accessing mental health care plus case management calls. The interventionist will also be available to assist with referrals for connection to other services later during the study period as needed for up to three months. The intervention may include contact with the youth's mental health provider to make sure linkages are made.
Other Names:
  • Suicidal Teens Accessing Treatment - Primary Care
Experimental: Youth-Nominated Support Team (YST-III)
This group will participate in a brief, suicide prevention intervention originally developed for youth who have been psychiatrically hospitalized due to a suicide attempt or suicidal ideation that has been adapted.
YST-III is an adapted version of Youth-Nominated Support Team for Suicidal Adolescents (YST-II). The intervention is a brief intervention originally developed for youth who have been psychiatrically hospitalized due to a suicide attempt or suicidal ideation (SI). Participants will nominate supportive adults (age 18 and older) from their lives who agree to provide ongoing contact and support for up to 3 months. YST-III will include an introductory session with the youth who will nominate their support persons plus referrals for mental health services. The support persons will receive training and support on how to best support their youth partner and then ongoing calls to support them in working with their youth partner for up to 3 months.
Other Names:
  • Youth-Nominated Support Team- III

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in suicidal ideation as measured by the Adult Suicidal Ideation Questionnaire (ASIQ)
Time Frame: baseline and months 1, 3, 6, 9, and 12
ASIQ is a 25-item, self-report assessment of suicidal thoughts designed specifically for adult populations. Possible scores range from 1 (Not at All) to 6 (Extreme), with lower scores indicating less severe suicidal ideation (better outcome).
baseline and months 1, 3, 6, 9, and 12

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in number of mental healthcare service utilization as measured by Emergency Department Screen for Teens at Risk for Suicide (ED-STARS) mental health service utilization check list
Time Frame: baseline and months 1, 3, 6, 9, and 12
ED-STARS mental health service utilization check list will be used to assess the number of different types of mental health services that participants receive
baseline and months 1, 3, 6, 9, and 12
Change in number of suicide attempts
Time Frame: baseline and months 1, 3, 6, 9, and 12
measured by the number of suicide attempts using the Columbia-Suicide Severity Rating Scale (CSSRS)
baseline and months 1, 3, 6, 9, and 12
Deaths by suicide
Time Frame: baseline to study completion up to 12 months
The data on any reported deaths due to suicide during the study period will be collected.
baseline to study completion up to 12 months
Change in depressive symptoms as measured by Center for Epidemiologic Studies Depression Scale-Revised CESD-R
Time Frame: baseline and months 1, 3, 6, 9, and 12
CESD-R is a 20-item measure of depression that assesses the duration symptoms across a period of two weeks. Possible scores range from 0-60, with lower scores indicating less depressive symptoms (better outcome).
baseline and months 1, 3, 6, 9, and 12
Change in social support as measured by the Multidimensional Scale of Perceived Social Support (MSPSS)
Time Frame: baseline and months 1, 3, 6, 9, and 12
12-item measure with three subscales that assesses family, friend, and significant other support. Response categories are on a 7-point Likert-scale from 1=very strongly disagree to 7=very strongly agree. The overall score will be used to assess change. The 12-item MSPSS scale has a mean continuous score ranging from 1-84. Higher scores indicate greater perceived social support (better outcome).
baseline and months 1, 3, 6, 9, and 12
Change in internalized stigma as measured by Internalized Transphobia Scale (ITS)-adapted
Time Frame: baseline and months 1, 3, 6, 9, and 12
an adapted version of the Internalized Transphobia Scale (ITS). The measure consists of 22 questions. Possible score ranges from 1-4 with lower scores indicating less internalized stigma (better outcome)
baseline and months 1, 3, 6, 9, and 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elizabeth Arnold, PhD, University of Kentucky

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 13, 2023

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Study Registration Dates

First Submitted

May 11, 2023

First Submitted That Met QC Criteria

May 11, 2023

First Posted (Actual)

May 22, 2023

Study Record Updates

Last Update Posted (Actual)

August 16, 2023

Last Update Submitted That Met QC Criteria

August 15, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified data will be deposited in the Patient-Centered Outcomes Data Repository as required by the funder.

IPD Sharing Time Frame

By the date that the Final Research Report is accepted by the funder

IPD Sharing Access Criteria

Researchers must go through the Patient-Centered Outcomes Data Repository to request access to the de-identified data through their process.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicidal Ideation

Clinical Trials on STAT-PC

3
Subscribe